Home › Castration-Resistant Prostatic Cancer › Washington › Seattle
Castration-Resistant Prostatic Cancer clinical trials in Seattle, WA
6 studies for Castration-Resistant Prostatic Cancer are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
RecruitingPhase 3
- VA Puget Sound Healthcare System, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
- University of Washington, Seattle
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 3
- Fred Hutch Cancer Center Sloan Clinic 2, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
- Fred Hutchinson Cancer Research Center, Seattle
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
RecruitingPhase 1/2
- Fred Hutchinson Cancer Center ( Site 0013), Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPhase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Castration-Resistant Prostatic Cancer trials in other cities
- Los Angeles, CA7 studies
- Houston, TX6 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Queens, NY4 studies
- Pittsburgh, PA4 studies
- Philadelphia, PA4 studies
- San Francisco, CA4 studies
- Nashville, TN3 studies
- Cincinnati, OH3 studies
- Minneapolis, MN3 studies
- Dallas, TX3 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.